-
Emtricitabine/tenofovir is an unbranded, ‘generic’ form of PrEP (pre-exposure prophylaxis). PrEP can reduce your risk of getting infected with HIV (human immunodeficiency virus). Emtricitabine/Tenofovir is currently out of stock.
Emtricitabine/tenofovir is the standard PrEP treatment in the UK. It works in the same way as Truvada, a branded version of PrEP which is typically prescribed in the US. To recieve this treatment you must be HIV negative and have a higher risk of HIV exposure. You also need to take certain tests before and while using PrEP. We explain more about these requirements, below.
Do you have a higher risk of getting HIV?
You might have a higher risk if you have sex without a condom with someone whose HIV status you’re unsure of, and you:
- are a man who has sex with men
- are transgender and have sex with men
- are a woman who has sex with bisexual partners
- have sex with someone from a country with a high rate of HIV
You may also have a higher risk if you:
- have sex with someone who is HIV positive and has a detectable viral load (meaning the amount of the virus in their blood is high enough that it can be found)
- take drugs using needles and share those needles with others
- are a sex worker
- get STIs (sexually transmitted infections) on a regular basis
There could be other factors that put you at a higher risk of getting HIV.
What tests do you need to take PrEP?
If you wanted to request emtricitabine/tenofovir from us, our doctors will ask whether you’ve had:
- a negative HIV test result
- a normal kidney function test result
- a negative hepatitis B and C test result — you only need a negative hepatitis B result if you’ve not had a hepatitis B vaccination, and you only need a negative hepatitis C result if you are a man who has sex with other men or are a trans woman
It’s also recommended that you do a full screen test for sexually transmitted infections (STIs).
You can continue to request PrEP if you haven’t had one or more of these tests. However, you must take these tests before you begin taking PrEP. You can order any PrEP tests you need from us and carry these out at home.
Prices
30 tablet(s) / 200/245 mg - £47.00
60 tablet(s) / 200/245 mg - £78.00
90 tablet(s) / 200/245 mg - £104.00
120 tablet(s) / 200/245 mg - £140.00
150 tablet(s) / 200/245 mg - £180.00
180 tablet(s) / 200/245 mg - £200.00



-
-
Emtricitabine/tenofovir is a medication that’s used to control HIV. The name of it refers to the active ingredients it contains: emtricitabine and tenofovir. It’s taken as a pre-exposure prophylaxis (PrEP) to prevent those with a high risk of exposure to HIV from catching it.
Emtricitabine/tenofovir does not cure HIV, although it can be used as part of treatment for those with HIV to prevent the infection spreading further.
What is Truvada?
Truvada is a branded version of emtricitabine/tenofovir. This means they work in the exact same way and they are just as effective as each other, only they may contain different non-active ingredients, and have a different name and price. Truvada is most commonly available in the US, whereas the unbranded ‘generic PrEP’ (emtricitabine/tenofovir) is more widely prescribed in the UK than Truvada.
-
-
Emtricitabine/tenofovir are antiviral drugs that work by protecting the body’s immune cells from HIV. The medication blocks the activity of the enzymes responsible for HIV and stops the virus from growing and spreading to other body cells. These medications do not cure HIV, but can help to prevent the infection if you have been exposed to it.
How long does emtricitabine/tenofovir take to work?
It takes about 7 days of daily use to have maximum protection when used for vaginal sex. When taken for anal sex, it is taken on demand and you can be protected within a couple of hours of the first double-dose.
Missing a dose of emtricitabine/tenofovir can make the medication less effective.
How long does emtricitabine/tenofovir stay in your system?
Research has estimated that it stays in your body for up to 7 days. The half-life of emtricitabine is approximately 10 hours, and the half-life of tenofovir is around 12 to 18 hours.
-
-
Emtricitabine/tenofovir has been found to be 86% effective for preventing HIV infection when taken as instructed.
Is emtricitabine/tenofovir effective after exposure?
If you’ve been exposed to HIV, and you’re taking PrEP as prescribed, you should be protected from the virus.
If you’re not currently taking PrEP and you think you’ve been exposed to HIV, you may need to start taking PEP (post-exposure prophylaxis) instead, not PrEP.
You should visit your local sexual health clinic for this. If it’s outside of normal working hours, go to your local A&E department instead.
Is emtricitabine/tenofovir safer than condoms?
Emtricitabine/tenofovir only protects you from HIV. Using a condom is a much safer option as condoms offer protection from a range of STIs, as well as HIV.
It’s recommended that you get tested for STIs every 3 months, including an HIV test.
Is undetectable HIV safe?
Studies have shown that people with an undetectable HIV viral load cannot pass on the virus to others. An ‘undetectable viral load’ means that the amount of the virus in their blood is not able to be found.
The PARTNER 2 study found that people taking effective HIV treatment with an undetectable viral load, did not pass on the virus to their sexual partners.
-
-
You should take emtricitabine/tenofovir, preferably with food, at the same time each day. It's important to take emtricitabine/tenofovir as prescribed by your doctor.
If your PrEP request is approved, carefully read the patient information leaflet that comes with your medication once you receive it. Do this before taking emtricitabine/tenofovir for the first time.
What dose of emtricitabine/tenofovir should you take?
We offer 200mg emtricitabine and 245mg tenofovir, to be taken daily. These are provided together (i.e. you do not need to request these separately).
What should you do if you miss a dose of emtricitabine/tenofovir?
If you forget to take your emtricitabine/tenofovir tablet for the day, but:
- remember within 12 hours of when you normally take it – you can still take it
- remember after 12 hours –skip that day’s dose and take it as usual the next day.
If you miss more than 2 doses in a week, then contact your doctor or a sexual health clinic.
What should you do if you take too much emtricitabine/tenofovir?
If you take more than your prescribed emtricitabine/tenofovir dose, go to your nearest sexual health clinic or call 111.
What is on-demand PrEP?
On-demand PrEP is taken only in situations where you have a high chance of getting HIV instead of taking it daily. This type of PrEP can provide effective protection for men when having anal sex without a condom. It is not recommended for vaginal sex.
PrEp on-demand works on a 2-1-1 schedule. This means that you take:
- 2 pills 2 to 24 hours before you have sex
- 1 pill 24 hours after the first dose
- 1 pill 24 hours after the second dose
If you continue to have sex for a longer period of time, then you should also keep taking 1 pill every 24 hours until you have not had sex for 2 days.
What is event-driven PrEP?
Event-driven PrEP is similar to on-demand PrEP. It is when you take PrEP when you want to have sex. It can be taken using the 2-1-1 schedule, like on-demand PrEP, or it can be used on a 2-7 schedule. The 2-7 schedule involves taking a double dose of PrEP before sex and then taking a pill daily for the next 7 days. This can also be an option for people having vaginal sex.
-
-
We can prescribe emtricitabine/tenofovir to you if you are over 18 years old, have tested HIV negative, and have a higher risk of getting HIV. Our doctors will check that the treatment is suitable for you.
You might have a higher risk if you have sex without a condom with someone whose HIV status you’re unsure of, and you:
- are a man who has sex with men
- are transgender and have sex with men
- are a woman who has sex with bisexual partners
- have sex with someone from a country with a high rate of HIV
You may also have a higher risk if you:
- have sex with someone who is HIV positive and has a detectable viral load (meaning the amount of the virus in their blood is high enough that it can be found)
- take drugs using needles and share those needles with others
- are a sex worker
- get STIs (sexually transmitted infections) on a regular basis
There could be other factors that put you at a higher risk of getting HIV.
Who should not take emtricitabine/tenofovir?
If you have a low risk of getting HIV, you do not need to take emtricitabine/tenofovir.
If you are HIV positive, you should not take emtricitabine/tenofovir on its own, as you may develop resistance to full HIV treatment.
It may also be unsuitable to take emtricitabine/tenofovir if:
- you’re under 18 years old
- you have liver disease
- you have kidney disease
- you have an allergy to any of the ingredients in emtricitabine/tenofovir
- you’re taking any other type of antiviral medication
- you’re taking a regular high dose of painkillers
- you have any rare conditions relating to lactose intolerance
- you’re on a low-phosphate diet
- you’re pregnant, breastfeeding, or trying to have a baby
If you fall into any of these categories but you have a high risk of HIV exposure, talk to a doctor. They can tell you about appropriate ways to protect yourself.
Can you take emtricitabine/tenofovir with other medications?
It’s important to tell your doctor about any medicines you’re taking before you start a course of emtricitabine/tenofovir. This includes any over-the-counter drugs.
Some medications may affect emtricitabine/tenofovir and cause problems with your kidneys. Talk to your doctor if you’re taking:
- any drugs for treating fungal infections
- any drugs for treating viral infections
- antibiotics
- painkillers like Ibuprofen
- medications for treating hepatitis C
- cancer drugs
Can you drink alcohol while taking emtricitabine/tenofovir?
Emtricitabine/tenofovir is not known to cause any interactions with alcohol, so you can still drink while taking it. However, note that if you do not drink alcohol in moderation while taking the medication, it may increase your chances of side effects.
-
-
ZAVA’s PrEP service is currently long-term out of stock, so we can’t offer PrEP online right now.
If you do decide to order PrEP online, make sure you use a regulated and trusted service so you can be sure you’re getting treatment which is safe and right for you.
-
-
Before you begin taking emtricitabine/tenofovir, our doctors will check whether you’ve had:
- a negative HIV test result
- a normal kidney function test result
- a negative hepatitis B and C test result — you only need a negative hepatitis B result if you’ve not had a hepatitis B vaccination, and you only need a negative hepatitis C result if you are a man who has sex with other men or are a trans woman
We will ask about these tests when you complete our online questionnaire to request treatment. Once you begin taking PrEP, you will need to repeat these tests at different periods too.
Why are these tests important?
HIV test
It may be unsafe to take PrEP if you’re HIV positive. The antiviral drugs in PrEP (emtricitabine and tenofovir) are often used to treat people with HIV, alongside other medications. You can become resistant to these drugs if you use them when you’re already HIV positive. This can make it more challenging to treat the infection later on.
If you have flu-like symptoms after unprotected sex, like a fever or a rash, you should check that you’re HIV negative before taking PrEP. You may need to take PEP instead. Scroll up to learn more (‘Is emtricitabine/tenofovir effective after exposure?’).
Different HIV tests have different timeframes for testing after unprotected sex. Follow the instructions for your chosen test to make sure the results are accurate.
Our HIV test kit is over 99% accurate at detecting HIV if you test 6 weeks after possible exposure to HIV. You can test any time before that, but if you get a negative result, you should repeat your test to make sure your results are accurate.
Kidney function
The two antiviral drugs in PrEP are used by the body and then passed out in your urine through your kidneys. You need to check that your kidneys are working properly otherwise these drugs can build up in your body and cause damage.
Hepatitis B and C
If you have hepatitis, taking and subsequently stopping PrEP can lead to a flare up of liver inflammation and your hepatitis getting worse. It can also affect any future hepatitis treatment you receive and make it harder to treat your condition.
What are the side effects of emtricitabine/tenofovir?
As with all medications, emtricitabine/tenofovir can have side effects. These usually go away within a few weeks. Most people don’t experience any side effects.
Common side effects of emtricitabine/tenofovir include:
- feeling sick and being sick (vomiting)
- diarrhoea
- headaches
- dizziness
- feeling weak
- pain in the stomach
- feeling bloated
- problems with sleeping
- rashes or swelling of the skin
Less common side effects include:
- anaemia (a lack of red blood cells, or haemoglobin, in the blood)
- muscle weakness and pain
- yellow and itchy eyes
- pain in the bones
- joint stiffness
- back pain
- a condition called lactic acidosis, where lactic acid builds up in the body, causing drowsiness and difficulty with breathing
If you experience any serious side effects, you should go to A&E immediately.
-
-
We offer further information about the following areas of HIV, covering:
- symptoms of HIV
- HIV skin rashes
- HIV testing and HIV test kits
The NHS has information on:
Terrence Higgins Trust provides information on:
Naz offers information and support around:
Depending on your background and circumstances, you can find more information:
- if you’re transgender through Mermaids
- about psychological therapies through the NHS
- about HIV prevention and works to fight against HIV stigma through the Gay men’s health project
- on drugs and chemsex from your local sexual health clinic or on Dean Street Clinic’s website
Several sources provide more information about PrEP and how it’s used. These include:

Brenda studied medicine at St Georges University of London and has most recently worked in John Radcliffe Oxford University Hospitals, covering acute and general medicine.
Meet our doctorsLast reviewed: 08 Jul 2022
-
NHS (2019). HIV and AIDS [online] Available at: https://www.nhs.uk/conditions/hiv-and-aids [accessed July 2025]
-
Rodger, A. J. et al (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. [online] The Lancet. Available at: https://pubmed.ncbi.nlm.nih.gov/31056293/ [accessed July 2025]
-
The National AIDS Treatment Advocacy Project (2019). Conference Reports: Estimated Time to Protection and Duration of Protection With Daily TDF/FTC PrEP. [online] Available at: https://www.natap.org/2014/Pharm/Pharm_05.htm [accessed July 2025]
-
World Atlas (2019). Countries With the Highest Rates of HIV/AIDs. [online] Available at: https://www.worldatlas.com/articles/countries-with-the-highest-rates-of-hiv-aids.html [accessed July 2025]
-
Landmark study confirms effectiveness of PrEP, GOV.UK [accessed July 2025]
In stock. Prices from £47.00